AKT1 and melanoma: Furthermore, reduced levels of TAp73 and ΔNp73 were observed in BRAFi-resistant primary melanoma cells with the activation of the PI3K/AKT pathway, while increased levels of TAp73 and ΔNp73 were detected in resistant metastatic melanoma cells with the re-activation of the MAPK pathway [79].